eXp Realty Incentivizes Teams To Join With New Equity Incentive

“Thrive” program designed to attract culturally aligned teams

eXp Realty Incentivizes Teams To Join With New Equity Incentive

“Thrive” program designed to attract culturally aligned teams

BELLINGHAM, Wash., Oct. 26, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), is excited to announce the launch of its new Thrive program, designed to incentivize culturally aligned, producing teams to join the eXp Realty family.

Once onboarded, the team lead will receive an equity award based on their previous 12-month production, subject to future vesting.

“As a company committed to continuously pushing the boundaries in support of our agents, eXp Realty is always looking for new ways to enhance the agent experience,” said Michael Valdes, Chief Growth Officer, eXp Realty. “Earlier this year, we introduced two incentive programs, Boost and Accelerate, aimed at helping independent brokerages and individual agents transition to eXp Realty. Now with the addition of Thrive, we are offering teams an accelerated equity opportunity. We understand that each team has its own unique culture and way of doing business, and we want to provide a platform for them to thrive in our agent-centric environment.”

eXp Realty will provide this equity incentive to team leads of culturally aligned teams with more than 10 agents in addition to the team lead and a minimum of $40 million (U.S./CAD) in sales volume in the originating country over the previous 12-month fiscal period. International qualifications to be released. Additional qualifications apply. A core criteria of this program is for team leads to commit to team training and ensuring their team members integrate with the eXp Realty ecosystem as part of their cultural alignment with eXp.

The Thrive incentive program is rolling out in the United States and Canada immediately and will soon be available in eXp’s additional 22 global markets, subject to applicable law. To learn more about eXp Realty’s new Thrive program and how it can benefit your team, please click here.

About eXp World Holdings, Inc.

eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty®, Virbela® and SUCCESS® Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 89,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud-based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS® Enterprises, anchored by SUCCESS® magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com

Safe Harbor Statement

The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Examples of such forward-looking statements include, but are not limited to, the availability of incentive programs in international markets and the future value of financial incentive programs. Such forward-looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward-looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company’s Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10-Q and Annual Report on Form 10-K.

Media Relations Contact:

eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Investor Relations Contact:

Denise Garcia
investors@expworldholdings.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5ef130bf-acbf-422b-a1dc-ae586120d6b8

GlobeNewswire Distribution ID 8966874

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience at the Global Health Exhibition

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience

RIYADH, Saudi Arabia, Oct. 26, 2023 (GLOBE NEWSWIRE) — At the 2023 Global Health Exhibition in Riyadh, King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its advanced approach to elevating the patient treatment journey. By harnessing state-of-the-art digital healthcare solutions, the hospital has showcased the role of such tools in enhancing healthcare outcomes and operational efficiency across diverse medical domains.

KFSH&RC has achieved substantial advancements in streamlining the patient admission process through the ‘Ehalat’ service. This automated platform simplifies medical referrals and fosters collaboration with both public and private healthcare entities. Additionally, it empowers users to submit medical reports, compile personal data, and access their medical history—all within a unified service, eliminating the necessity for in-person visits to the hospital. This not only simplifies the evaluation of a patient’s condition and treatment eligibility but also provides real-time tracking and updates on applications.

Patients can now track their treatment progress remotely through “Altakhassusi” mobile application, providing them with secure access to their medical records. The app allows patients to view radiology and medical lab test results, easily schedule appointments, attend virtual follow-up sessions with their physicians, and even assess the effectiveness of their treatment. Moreover, it enhances the process of prescription refills, medical supplies, and nutritional needs, making communication with the medical team and the hospital effortless.

KFSH&RC is dedicated to providing a high-quality treatment experience with automation at every stage. This approach saves time and effort for patients, and it improves medical decision-making through cutting-edge methods and care models that leverage the rapid advancements in digital health innovations. These capabilities enable seamless integration of various medical technologies, consolidating clinical results, documents, and medical data. This ranges from surgical notes to post-operative care, ensuring a smooth flow of information, boosting care efficiency, and customizing it to meet each patient’s unique needs.

KFSH&RC is globally recognized for its exceptional specialized healthcare services and groundbreaking innovations. It stands as an advanced hub for medical research and education, committed to advancing medical technologies and raising the standard of healthcare on a global scale. Through collaborations with prominent local, regional, and international institutions, it aspires to deliver world-class services in clinical care, research, and education.

The Global Health Exhibition, featuring the participation of 250 exhibitors from 15 countries, stands as the premier healthcare gathering in the Middle East. It serves as a platform for collaboration among Saudi and global healthcare communities, including regional and international manufacturers and suppliers. This year’s summit, operating under the theme ‘Investing in Health,’ promises to be a pivotal event shaping the future of healthcare.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2825a442-d3e8-4c08-aa98-61fb48e4fe5e

GlobeNewswire Distribution ID 8966676

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience at the Global Health Exhibition

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience

RIYADH, Saudi Arabia, Oct. 26, 2023 (GLOBE NEWSWIRE) — At the 2023 Global Health Exhibition in Riyadh, King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its advanced approach to elevating the patient treatment journey. By harnessing state-of-the-art digital healthcare solutions, the hospital has showcased the role of such tools in enhancing healthcare outcomes and operational efficiency across diverse medical domains.

KFSH&RC has achieved substantial advancements in streamlining the patient admission process through the ‘Ehalat’ service. This automated platform simplifies medical referrals and fosters collaboration with both public and private healthcare entities. Additionally, it empowers users to submit medical reports, compile personal data, and access their medical history—all within a unified service, eliminating the necessity for in-person visits to the hospital. This not only simplifies the evaluation of a patient’s condition and treatment eligibility but also provides real-time tracking and updates on applications.

Patients can now track their treatment progress remotely through “Altakhassusi” mobile application, providing them with secure access to their medical records. The app allows patients to view radiology and medical lab test results, easily schedule appointments, attend virtual follow-up sessions with their physicians, and even assess the effectiveness of their treatment. Moreover, it enhances the process of prescription refills, medical supplies, and nutritional needs, making communication with the medical team and the hospital effortless.

KFSH&RC is dedicated to providing a high-quality treatment experience with automation at every stage. This approach saves time and effort for patients, and it improves medical decision-making through cutting-edge methods and care models that leverage the rapid advancements in digital health innovations. These capabilities enable seamless integration of various medical technologies, consolidating clinical results, documents, and medical data. This ranges from surgical notes to post-operative care, ensuring a smooth flow of information, boosting care efficiency, and customizing it to meet each patient’s unique needs.

KFSH&RC is globally recognized for its exceptional specialized healthcare services and groundbreaking innovations. It stands as an advanced hub for medical research and education, committed to advancing medical technologies and raising the standard of healthcare on a global scale. Through collaborations with prominent local, regional, and international institutions, it aspires to deliver world-class services in clinical care, research, and education.

The Global Health Exhibition, featuring the participation of 250 exhibitors from 15 countries, stands as the premier healthcare gathering in the Middle East. It serves as a platform for collaboration among Saudi and global healthcare communities, including regional and international manufacturers and suppliers. This year’s summit, operating under the theme ‘Investing in Health,’ promises to be a pivotal event shaping the future of healthcare.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2825a442-d3e8-4c08-aa98-61fb48e4fe5e

GlobeNewswire Distribution ID 8966676

LeddarTech Unveils LeddarCar at Reuters Automotive USA 2023 on November 8-9 in Detroit, Demonstrating Next-Gen Sensor Fusion and Perception Software for ADAS Applications

QUEBEC CITY, Oct. 25, 2023 (GLOBE NEWSWIRE) — LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, is pleased to announce its participation as a speaker and on-site exhibitor along with demonstrating its technology live with the LeddarCar at the Automotive USA 2023 conference on November 8-9, Huntington Place, Detroit, MI.

The Automotive USA 2023 event has become an industry hallmark, and this year’s edition promises to be a new milestone in automotive innovation. LeddarTech’s software solutions have received several awards and honors this year, with most recently being granted the UK-based AutoTech Breakthrough announced on October 4, 2023 that LeddarVision™ Front-Entry-Level (LVF-E) has been selected as winner of the Advanced Driver Assistance System of the Year award.

November 8-9: EXPERIENCE LeddarTech’s award-winning interactive dashboard demonstration at booth #18 featuring LeddarVision, a high-performance, scalable, cost-efficient automotive low-level sensor fusion and perception software solution that is also hardware and processor-agnostic.

Also featuring LeddarVision-inspired ADAS products:

  • LVF-E, a front-view fusion and perception stack for entry-level ADAS L2/L2+ highway assist and 5-star NCAP 2025/GSR 2022
  • LVF-H, the premium companion fusion and perception stack in the front-view product family featuring extended sensor configuration
  • LVS-2+, the newly launched surround-view premium fusion and perception stack that efficiently extends the LVF front-view product family 1VxR sensor configuration to a 5V5R configuration

RIDE ALONG LeddarCar live: Delegates representing automotive Tier 1-2 suppliers and OEMs are invited to book a real-world on-road demonstration of LeddarTech’s LeddarVision low-level fusion and perception software technology. Space is limited, so reserve your LeddarCar on-road demo now.

LeddarTech Presents: On November 9 at 1:10 p.m., Pierre Olivier, LeddarTech’s Chief Technology Officer, will host a panel discussion entitled “Delivering a Safe Transition Towards Autonomous Vehicles.” Take a seat alongside fellow auto executives to engage, build partnerships and delve into a key challenge that the market is facing!

Pre-arrange a meeting for a product demonstration or to experience LeddarCar live.

About Automotive USA 2023

“Reuters Events: Automotive USA” is the industry gathering to unite senior-level OEM leaders who address how they will build software-defined electric vehicles, reshape the OEM business model and plan for an autonomous future. Reaching a North American audience, this event shapes future strategies across business-critical topics, including electrification, connectivity, autonomous vehicles, sustainability, supply chain and more.

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech’s automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

LeddarTech is responsible for several remote-sensing innovations, with over 150 patent applications (80 granted) that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.LeddarTech.com and on LinkedIn, Twitter (X), Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

GlobeNewswire Distribution ID 8952473

King Faisal Specialist Hospital and Research Centre Announces Innovative Clinical Pharmacogenomics

Enhances Drug Effectiveness and Patient Safety

Genomic building – KFSH&RC

Genomic building – KFSH&RC

RIYADH, Saudi Arabia, Oct. 24, 2023 (GLOBE NEWSWIRE) — The King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the launch of the inaugural phase of its clinical pharmacogenomics service within its Heart Center. This pioneering service leverages the patient’s DNA to tailor drug dosages and selections, heralding a new era in healthcare that prioritizes personalized treatment for each individual. This groundbreaking approach is poised to enhance treatment outcomes and reduce potential harm.

KFSH&RC’s experts have said that this analysis empowers physicians to prescribe medications customized to each patient, factoring in their unique health conditions and genetic traits. Patients’ responses to pharmaceuticals can significantly differ based on their genetic profiles. As a result, what proves effective for one patient may have minimal impact in another. It is worth noting that statistics reveal that 15% of hospital admissions stem from adverse drug reactions, imposing substantial financial and human burdens on healthcare systems across the globe.

This innovative service is a collaborative endeavor between the Centre for Genomic Medicine, Healthcare Information Technology Affairs, and the Pharmaceutical Care Department at KFSH&RC. In its initial phase, this service encompasses six of the most frequently prescribed medications, as determined by hospital data, whose efficacy is known to be influenced by genetic variations.

KFSH&RC has made it clear that it remains committed to expanding the scope of this service progressively, encompassing all hospital departments. This expansion underscores the hospital’s unwavering dedication to providing personalized healthcare to every patient, ensuring the utmost level of safety, and minimizing harm, while adhering to the latest globally endorsed scientific practices.

At the Global Health Exhibition held in Riyadh from October 29th to 31st, where KFSH&RC plays a vital role as a strategic health partner, the hospital is set to unveil the innovative service that promises to advance healthcare outcomes in the region.

KFSH&RC stated that it is moving to gradually expand the scope of application of the service to include all medical specialties as part of its commitment to providing personalized health care for each patient at the highest level of safety and prevention of harm and to harness the latest scientifically proven practices around the world.

King Faisal Specialist Hospital and Research Center is considered among the most prominent in the world in providing specialized health care, a pioneer in innovation, and an advanced medical research and education center. It also seeks to develop medical technologies and raise health care worldwide in partnership with prominent local, regional and international institutions. To achieve world-class service in the clinical, research, and educational fields.

Contact information:

kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9e826983-52ae-4fe5-8579-0cbdfcca9d1c

GlobeNewswire Distribution ID 8964787